Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

OMTH IPO Bombs

|Includes:Omthera Pharmaceuticals (OMTH)

Originally listed around $5 below target IPO, and now down $.70 on top of that. I believe the market has spoken, not too interested in chasing a market size similar to a generic Lovaza.

Stocks: OMTH